Uveitis Drug Bonanza?
November 20, 2014 at 11:48 AM EST
With a sense of urgency I received this pitch (in a nutshell) Institutions and insiders – including the FDA’s former Chief Counsel – have snapped up 83% of available shares of the amazing company I’ve been telling you about. And for good reason. This tiny $4 company has developed a breakthrough drug to treat a […]